Takashi Murata

Kyoto Medical Center — Japan

Medicine · Health Sciences

17h-index1.2kcitations122works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Management and Research(41), Diabetes Treatment and Management(21), Diabetes and associated disorders(15), Diabetes Management and Education(13), Pancreatic function and diabetes(11)

Publications121 total

Association of impaired awareness of hypoglycemia and real-time continuous glucose monitoring with the occurrence and frequency of severe hypoglycemia in adults with type 1 diabetes mellitus: a real-world panel data analysis from the PR-IAH study
Diabetology International·2025
Comparing the Validity of Three Methods for Identifying Impaired Awareness of Hypoglycemia in Predicting Severe Hypoglycemia in Adults with Type 1 Diabetes Mellitus: The PR-IAH Study
Internal Medicine·2025· 1 citedOpen Access
950-P: A Multicenter Retrospective Observational Study of the Safety and the Effectiveness of the MEDISAFE WITH Patch Insulin Pump—MW-Safety Study
Diabetes·2025
631-P: Increasing Sleep Duration among Short-Sleeping Type 2 Diabetes Patients via mHealth—A Pilot Randomized Controlled Trial
Diabetes·2025· 1 cited
Efficacy of a Personalized Mobile Health Intervention (BedTime) to Increase Sleep Duration Among Short-Sleeping Patients With Type 2 Diabetes: Protocol for a Pilot Randomized Controlled Trial
JMIR Research Protocols·2025Open Access
The Relationship Between the Percent Coefficient of Variation of Sensor Glucose Levels and the Risk of Severe Hypoglycemia or Non-Severe Hypoglycemia in Patients With Type 1 Diabetes: Post Hoc Analysis of the ISCHIA Study
Journal of Diabetes Science and Technology·2025· 3 citedOpen Access
Associations between clustering of hypoglycemic symptoms, psychological traits, and problem-solving abilities in adults with type 1 diabetes: baseline data analysis of the PR-IAH study
Diabetology International·2025· 2 citedOpen Access
Sex Differences in Renal Outcomes and Metabolic Markers by Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists in Individuals with Type 2 Diabetes: A Post-Hoc Analysis of the RECAP Study
JMA Journal·2025Open Access
Cost-effective analysis focused on hypoglycemia of intermittent-scanning continuous glucose monitoring in type 1 diabetes adults: a ISCHIA randomized clinical trial
Diabetology International·2024Open Access
Comparison of Points in Range Measured by the Self-monitoring of Blood Glucose and Time in Range Measured by the Continuous Glucose Monitoring.
PubMed·2024
Diurnal variation in the association between the scan frequency of isCGM and CGM metrics: post hoc analysis of the ISCHIA study
Diabetology International·2024Open Access
Efficacy of a Personalized Mobile Health Intervention (BedTime) to Increase Sleep Duration Among Short-Sleeping Patients With Type 2 Diabetes: Protocol for a Pilot Randomized Controlled Trial (Preprint)
2024Open Access
Association of hypoglycemia problem-solving abilities with severe hypoglycemia in adults with type 1 diabetes: a Poisson regression analysis
Diabetology International·2024· 4 citedOpen Access
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined <scp>sodium‐glucose cotransporter‐2</scp> inhibitor and <scp>glucagon‐like peptide</scp> ‐1 receptor agonist treatment in patients with type 2 diabetes and <scp>chronic kidney disease</scp>
Diabetes Obesity and Metabolism·2024· 4 citedOpen Access
Author response for "Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined &lt;scp&gt;sodium‐glucose cotransporter‐2&lt;/scp&gt; inhibitor and &lt;scp&gt;glucagon‐like peptide&lt;/scp&gt;‐1 receptor agonist treatment in patients with type 2 diabetes and &lt;scp&gt;chronic kidney disease&lt;/scp&gt;"
2024
Author response for "Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined &lt;scp&gt;sodium‐glucose cotransporter‐2&lt;/scp&gt; inhibitor and &lt;scp&gt;glucagon‐like peptide&lt;/scp&gt;‐1 receptor agonist treatment in patients with type 2 diabetes and &lt;scp&gt;chronic kidney disease&lt;/scp&gt;"
2024
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study
Frontiers in Pharmacology·2024· 7 citedOpen Access
Predictors of the effectiveness of isCGM usage in adults with type 1 diabetes mellitus: post-hoc analysis of the ISCHIA study
Diabetology International·2024· 1 citedOpen Access
Difference in the accuracy of the third-generation algorithm and the first-generation algorithm of FreeStyle Libre continuous glucose monitoring device
The Journal of Medical Investigation·2024· 2 citedOpen Access
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication
Diabetes and Vascular Disease Research·2023· 8 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Naoki Sakane(18), Yoshimasa Tanaka(10), Masao Toyoda(10), Ken Kato(9), Atsuhito Tone(9), Akiko Suganuma(9), Yushi Hirota(8), Kazunori Yamada(6), K Akagi(6), Moritsugu Kimura(6), Akio Kuroda(5), Junnosuke Miura(5), Kiminori Hosoda(5), Munehide Matsuhisa(5), Tomokazu Watanabe(5), Satoshi Kawashima(5), Kenji Nagata(5), Shinsuke Nirengi(5), Masayuki Domichi(5), Seiko Sakane(5)